Early results of a coronavirus vaccine study being conducted in Colorado show that the vaccine candidate in older adults produced virus-neutralizing antibodies at levels similar to those seen in younger adults.
Early results of a coronavirus vaccine study being conducted in Colorado show that the vaccine candidate in older adults produced virus-neutralizing antibodies at levels similar to those seen in younger adults.